Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Zhang, Yun; Pötter, Sebastian; Chen, Chih-Wei; Liang, Ruifang; Gelse, Kolja; Ludolph, Ingo; Horch, Raymund E; Distler, Oliver; Schett, Georg; Distler, Jörg H W; Dees, Clara (2018). Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis. Annals of the Rheumatic Diseases, 77(5):744-751.

Bergmann, Christina; Brandt, Amelie; Merlevede, Benita; Hallenberger, Ludwig; Dees, Clara; Wohlfahrt, Thomas; Pötter, Sebastian; Zhang, Yun; Chen, Chih-Wei; Mallano, Tatiana; Liang, Ruifang; Kagwiria, Rosebeth; Kreuter, Alexander; Pantelaki, Ioanna; Bozec, Aline; Abraham, David; Rieker, Ralf; Ramming, Andreas; Distler, Oliver; Schett, Georg; Distler, Jörg H W (2018). The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis. Annals of the Rheumatic Diseases, 77(1):150-158.

Huang, Jingang; Maier, Christiane; Zhang, Yun; Soare, Alina; Dees, Clara; Beyer, Christian; Harre, Ulrike; Chen, Chih-Wei; Distler, Oliver; Schett, Georg; Wollin, Lutz; Distler, Jörg H W (2017). Nintedanib macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis. Annals of the Rheumatic Diseases, 76(11):1941-1948.

Zhang, Yun; Liang, Ruifang; Chen, Chih-Wei; Mallano, Tatjana; Dees, Clara; Distler, Alfiya; Reich, Adam; Bergmann, Christina; Ramming, Andreas; Gelse, Kolja; Mielenz, Dirk; Distler, Oliver; Schett, Georg; Distler, Jörg H W (2017). JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment. Annals of the Rheumatic Diseases, 76(8):1467-1475.

Liang, Ruifang; Šumová, Barbora; Cordazzo, Cinzia; Mallano, Tatjana; Zhang, Yun; Wohlfahrt, Thomas; Dees, Clara; Ramming, Andreas; Krasowska, Dorota; Michalska-Jakubus, Małgorzata; Distler, Oliver; Schett, Georg; Šenolt, Ladislav; Distler, Jörg H W (2016). The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc. Annals of the Rheumatic Diseases, 76(4):756-764.

Dees, Clara; Beyer, Christian; Distler, Alfiya; Soare, Alina; Zhang, Yun; Palumbo-Zerr, Katrin; Distler, Oliver; Schett, Georg; Sandner, Peter; Distler, Jörg H W (2015). Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies. Annals of the Rheumatic Diseases, 74(8):1621-1625.

Beyer, Christian; Huang, Jingang; Beer, Jürgen; Zhang, Yun; Palumbo-Zerr, Katrin; Zerr, Pawel; Distler, Alfiya; Dees, Clara; Maier, Christiane; Munoz, Louis; Krönke, Gerhard; Uderhardt, Stefan; Distler, Oliver; Jones, Simon; Rose-John, Stefan; Oravecz, Tamas; Schett, Georg; Distler, Jörg Hw (2015). Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages. Annals of the Rheumatic Diseases, 74(6):1317-1324.

Zhang, Yun; Dees, Clara; Beyer, Christian; Lin, Neng-Yu; Distler, Alfiya; Zerr, Pawel; Palumbo, Katrin; Susok, Laura; Kreuter, Alexander; Distler, Oliver; Schett, Georg; Distler, Jörg H W (2015). Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis. Annals of the Rheumatic Diseases, 74(5):936-943.

Distler, Alfiya; Lang, Veronika; Del Vecchio, Tina; Huang, Jingang; Zhang, Yun; Beyer, Christian; Lin, Neng-Yu; Palumbo-Zerr, Katrin; Distler, Oliver; Schett, Georg; Distler, Jörg H W (2014). Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability. Annals of the Rheumatic Diseases, 73(6):1264-1268.

This list was generated on Mon Dec 17 18:02:49 2018 CET.